Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Long-term metastable conformation of human Fcgamma subunit.

Tischenko VM, Zav'yalov VP.

Immunol Lett. 2002 Dec 3;84(3):241-5.

PMID:
12413743
2.

The IgG binding site of human FcgammaRIIIB receptor involves CC' and FG loops of the membrane-proximal domain.

Tamm A, Kister A, Nolte KU, Gessner JE, Schmidt RE.

J Biol Chem. 1996 Feb 16;271(7):3659-66.

3.

An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.

Vafa O, Gilliland GL, Brezski RJ, Strake B, Wilkinson T, Lacy ER, Scallon B, Teplyakov A, Malia TJ, Strohl WR.

Methods. 2014 Jan 1;65(1):114-26. doi: 10.1016/j.ymeth.2013.06.035. Epub 2013 Jul 17.

PMID:
23872058
4.

Human IgG subclass cross-species reactivity to mouse and cynomolgus monkey Fcγ receptors.

Derebe MG, Nanjunda RK, Gilliland GL, Lacy ER, Chiu ML.

Immunol Lett. 2018 May;197:1-8. doi: 10.1016/j.imlet.2018.02.006. Epub 2018 Feb 21.

PMID:
29476755
5.

Tandemly repeated Fc domain augments binding avidities of antibodies for Fcgamma receptors, resulting in enhanced antibody-dependent cellular cytotoxicity.

Nagashima H, Tezuka T, Tsuchida W, Maeda H, Kohroki J, Masuho Y.

Mol Immunol. 2008 May;45(10):2752-63. doi: 10.1016/j.molimm.2008.02.003. Epub 2008 Mar 18.

PMID:
18353438
6.

Structural basis of the interaction between IgG and Fcgamma receptors.

Kato K, Sautès-Fridman C, Yamada W, Kobayashi K, Uchiyama S, Kim H, Enokizono J, Galinha A, Kobayashi Y, Fridman WH, Arata Y, Shimada I.

J Mol Biol. 2000 Jan 14;295(2):213-24.

PMID:
10623521
8.

Structural analysis of Fc/FcγR complexes: a blueprint for antibody design.

Caaveiro JM, Kiyoshi M, Tsumoto K.

Immunol Rev. 2015 Nov;268(1):201-21. doi: 10.1111/imr.12365. Review.

PMID:
26497522
9.

Immunochemical study of a human myeloma IgG1 half molecule.

Seligmann M, Mihaesco E, Chevalier A, Miglierina R.

Ann Immunol (Paris). 1978 Oct-Dec;129 C(6):855-70.

PMID:
85430
10.

Structural basis for binding of human IgG1 to its high-affinity human receptor FcγRI.

Kiyoshi M, Caaveiro JM, Kawai T, Tashiro S, Ide T, Asaoka Y, Hatayama K, Tsumoto K.

Nat Commun. 2015 Apr 30;6:6866. doi: 10.1038/ncomms7866.

11.

Recognition of IgG by Fcgamma receptor. The role of Fc glycosylation and the binding of peptide inhibitors.

Radaev S, Sun PD.

J Biol Chem. 2001 May 11;276(19):16478-83. Epub 2001 Jan 31.

12.
13.

Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.

Van den Hoecke S, Ehrhardt K, Kolpe A, El Bakkouri K, Deng L, Grootaert H, Schoonooghe S, Smet A, Bentahir M, Roose K, Schotsaert M, Schepens B, Callewaert N, Nimmerjahn F, Staeheli P, Hengel H, Saelens X.

J Virol. 2017 Mar 13;91(7). pii: e02500-16. doi: 10.1128/JVI.02500-16. Print 2017 Apr 1.

14.

Construction and expression of mouse-human chimeric antibody SZ-51 specific for activated platelet P-selectin.

Gu J, Liu Y, Xia L, Wan H, Li P, Zhang X, Ruan C.

Thromb Haemost. 1997 Apr;77(4):755-9.

PMID:
9134655
15.

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.

Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P.

J Mol Biol. 2003 Jan 31;325(5):979-89.

PMID:
12527303
16.

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.

Morrison SL, Johnson MJ, Herzenberg LA, Oi VT.

Proc Natl Acad Sci U S A. 1984 Nov;81(21):6851-5.

17.

Stoichiometry and thermodynamics of the interaction between the Fc fragment of human IgG1 and its low-affinity receptor Fc gamma RIII.

Ghirlando R, Keown MB, Mackay GA, Lewis MS, Unkeless JC, Gould HJ.

Biochemistry. 1995 Oct 17;34(41):13320-7.

PMID:
7577916
18.

Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.

Quast I, Keller CW, Maurer MA, Giddens JP, Tackenberg B, Wang LX, Münz C, Nimmerjahn F, Dalakas MC, Lünemann JD.

J Clin Invest. 2015 Nov 2;125(11):4160-70. doi: 10.1172/JCI82695. Epub 2015 Oct 5.

19.

Generation of a high-affinity Fcgamma receptor by Ig-domain swapping between human CD64A and CD16A.

Ellsworth JL, Hamacher N, Harder B, Maurer M, Bukowski TR, Lantry M, Noriega C, Rixon MW, Fox B, Lewis K, Meengs B, Rollins E, Greeff K, Meyer J, Birks C.

Protein Eng Des Sel. 2010 Apr;23(4):299-309. doi: 10.1093/protein/gzq007. Epub 2010 Feb 11.

PMID:
20150179
20.

The membrane anchor influences ligand binding two-dimensional kinetic rates and three-dimensional affinity of FcgammaRIII (CD16).

Chesla SE, Li P, Nagarajan S, Selvaraj P, Zhu C.

J Biol Chem. 2000 Apr 7;275(14):10235-46.

Supplemental Content

Support Center